Clinical trial

Study of Eszopiclone Compared to Placebo on Daytime Function in Subjects With Insomnia Related to Rheumatoid Arthritis

NCT00367965

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-02-01

PhasePHASE3

Study timeline

Study start (unknown)2004-02-01Date precision: month

Registry last updated2012-02-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Insomniaunresolved

Arthritis, Rheumatoidunresolved

Interventions

EszopicloneDRUG · verified · RxNorm: eszopiclone

placeboDRUG

Sponsors & collaborators

Sumitomo Pharma America, Inc.lead sponsor

Mapped research locations

DallasTexas, United States1 St LouisMissouri, United States1 TampaFlorida, United States1 Washington D.C.District of Columbia, United States1 Oklahoma CityOklahoma, United States1 RochesterNew York, United States1 TucsonArizona, United States1 Winston-SalemNorth Carolina, United States1 LouisvilleKentucky, United States1 MemphisTennessee, United States1 Kansas CityKansas, United States1 Fort LauderdaleFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00367965 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.